[1]  Lauterbur P C. Image formation by induced local interaction: examples employing nuclear magnetic resonance[J]. Nature, 1973, 242: 190-191.
[2]  Damadian R, Minkoff L, Goldsmith M, et al. Field focusing nuclear magnetic resonance (FONAR): visualization of a tumor in a live animal[J].  Science, 1976, 194: 1 430-1 432.
[3]  Buxton R. Introduction to functional magnetic resonance Imaging: Principles and Techniques[M]. Cambridge University Press, 2002. 
[4]  Blümich B. NMR Imaging of Materials[M]. Oxford: Clarendon Press,  2000.
[5]  Callaghan P T. Principles of Nuclear Magnetic Resonance Microscopy[M]. Oxford: Clarendon Press, 1991.
[6]  Liang Z P, Lauterbur P C.  Principles of magnetic resonance maging, A signal processing perspective[M]. New York: Spie Op-tical Engineering Press, 2000.
[7]  Zhu Donglin(俎栋林). Magnetic Resonamce Imaging(核磁共振成像学)[M]. Beijing(北京): Higher Education Press(高等教育出版社)， 2004.
[8]  Lauffer R B. Paramagnetic metal complexes as water proton relaxation agents for NMR imagining : theory and design[J]. Chem Rev, 1987, 87: 901-927.
[9]  Banci L, Bertini I, Luchinat C. Nuclear and Electronic Relaxation[M]. VCH, Weiheim, 1991.
[10]  Zhang Shan-rong(张善荣), Ren Ji-ming(任吉民), Pei Feng-kiu(裴奉奎). The research progress of MRI contrast agents[J\. Progress in Chemistry(化学进展), 1995, 7(2) : 98-112.
[11]  Peters J A, Huskens J, Raber D J.  Lanthanide induced shifts and relaxation rate enhancements[J]. Progress in Nuclear Magnetic Resonance Spectroscopy, 1996,  28(3/4): 283-350. 
[12]  Caravan P, Ellison J J, McMurry T J, et al. Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applica-tions[J]. Chem Rev, 1999, 99: 2 293-2 352.
[13]  Merbach A E. The Chemistry of Contrast Agents in Medical MRI[M]. Wiley: Chichester, 2001.
[14]  Yu Kai-chao(俞开潮)，Wang Guo-ping(王国平)，Ding Shang-wu(丁尚武)，et al. Recent progresses in the development of contrast agents used in magnetic resonance imaging(用于磁共振成像对比增强的造影剂研发进展)[J].  Chinese J  Magn  Reson(波谱学杂志), 2004, 21: 505-525.
[15]  Major J L， Meade T J. Bioresponsive, Cell-Penetrating, and Multimeric MR Contrast Agents[J]. Acc Chem Res, 2009, 42(7): 893-903.
[16]  Werner E J,  Datta A,  Jocher C J, et al. High-relaxivity MRI contrast agents: where coordination chemistry meets medical imaging[J].  Angew Chem, Int Ed, 2008, 47(45): 8 568-8 580.  
[17]  Raymond K N, Pierre V C. Next Generation, High Relaxivity Gadolinium MRI Agents[J]. Bioconjugate Chem,  2005, 16: 3-8. 
[18]  Louie A Y,  Huber M M,  Ahrens E T,  et al.  In vivo visualization of gene expression using magnetic resonance imaging[J]. Nat Biotechnol,  2000, 18: 321-325.
[19]  Alauddin M M, Louie A Y, Shahinian A, et al. Receptor mediated uptake of a radiolabeled contrast agent sensitive to β- galactosidase  activity[J]. Nucl Med Biol,  2003, 30: 261-265.
[20]  Urbanczyk-Pearson L M, Femia F J, Smith J, et al. Mechanistic investigation of β-galactosidase-activated MR contrast agents[J]. Inorg Chem,  2008, 47: 56-68.
[21]  Urbanczyk-Pearson, L M, Meade T J. Preparation of magnetic resonance contrast agents activated by β-galactosidase[J]. Nat Protoc,  2008, 3: 341-350.
[22]  Aime S, Cabella C, Colombatto S, et al. Insights into the use of paramagnetic Gd(III) complexes in MRmolecular imaging in-vestigations[J]. J Magn Reson Imaging, 2002, 16: 394-406.
[23]  Giardiello M, Lowe M P, Botta M. An esterase-activated magnetic resonance contrast agent[J]. Chem Commun, 2007, 4 044-4 046.
[24]  Yoo B, Pagel M D.  A PARACEST MRI contrast agent to detect enzyme activity[J]. J Am Chem Soc, 2006, 128： 14 032-14 033.
[25]  Berridge M J, Lipp P, Bootman M D. The versatility and universality of calcium signalling[J].  Nat Rev Mol Cell Biol, 2000, 1: 11-21.
[26]  Li W H, Fraser S E, Meade T J.  A calcium-sensitive magnetic resonance imaging contrast agent[J].  J Am Chem Soc, 1999, 121：1 413-1 414.
[27]  Li W H, Parigi G, Fragai M, et al. Mechanistic studies of a calcium-dependent MRI contrast agent[J]. Inorg Chem, 2002, 41： 4 018-4 024.
[28]  Dhingra K, Maier M E, Beyerlein M, et al. Synthesis and characterization of a smart contrast agent sensitive to calcium[J]. Chem Commun, 2008, 3 444-3 446.
[29]  Dhingra K, Fouskova P, Angelovski G, et al. Towards extracellular Ca²⁺ sensing by MRI: synthesis and calcium-dependent ¹H and ¹⁷O relaxation studies of two novel bismacrocyclic Gd³⁺ complexes[J]. JBIC, 2008, 13:  35-46.
[30]  Mlshra A, Fousková P, Angelovskl G, et al.  Facile synthesis and relaxation properties of novel bispolyazamacrocyclic Gd³⁺ complexes: An attempt towards calcium-sensitive MRI contrast agents[J]. Inorg Chem, 2008, 47：1 370-1 381.
[31]  Angelovskl G, Fousková P, Mamedov I, et al. Smart magnetic resonance imaging agents that sense extracellular calcium fluctua-tions[J]. Chem BioChem, 2008, 9: 1 729-1 734.
[32]  Frederickson C J, Koh J Y, Bush A I. The neurobiology of zinc in health and disease[J]. Nat Rev Neurosci,   2005, 6: 449-462.
[33]  Hanaoka K, Kikuchi K, Urano Y, et al.  Selective sensing of zinc ions with a novel magnetic resonance imaging contrast agent[J]. J Chem Soc, Perkin Trans, 2, 2001, 1 840-1 843.
[34]  Hanaoka K, Kikuchi, K, Urano Y, et al. Design and synthesis of a novel magnetic resonance imaging contrast agent for selective sensing of zinc Ion[J]. Chem Biol, 2002, 9(9): 1 027-1 032.
[35]  Major J L, Parigi G, Luchinat C, et al. The synthesis and in vitro testing of a zinc-activated MRI contrast agent[J]. Proc Natl Acad Sci U S A,  2007, 104(35): 13 881-13 886.
[36]  Major J L, Boiteau R M, Meade T J.  Mechanisms of ZnII-activated magnetic resonance imaging agents[J]. Inorg Chem, 2008, 47(22): 10 788-10 795.
[37]  Esqueda A C, Lopez J A, Andreu-de-Riquer G, et al.  A new gadolinium-based MRI zinc sensor[J]. J Am Chem Soc,  2009, 131(32): 11 387-11 391.
[38]  Que E L, Chang C J. A smart magnetic resonance contrast agent for selective copper sensing[J]. J Am Chem Soc, 2006, 128：15 942-15 943.
[39]  Que E L, Gianolio E, Baker S L, ET AL. Copper-responsive magnetic resonance imaging contrast agents[J]. J Am Chem Soc, 2009, 131: 8 527-8 536.
[40]  Zecca L, Youdim, Riederer P, et al. Iron, brain aging and neurodegenerative disorders[J]. Nat Rev Neurosci,  2004, 5(11): 863-873.
[41]  Livramento J B, To′ th E′, Sour A, et al. High relaxivity confined to a small molecular space: A metallostarbased, potential MRI contrast agen[J].  Angew Chem, Int Ed, 2005, 44: 1 480-1 484.
[42]  Parac-Vogt T N, Elst L V, Kimpe K, et al. Pharmacokinetic and in vivo evaluation of a self-assembled gadolinium(III)-iron(II) contrast agent with high relaxivity[J]. Contrast Media Mol Imaging, 2006, 1: 267-278.
[43]  Paris  J, Gameiro C, Humblet V, et al. Auto-assembling of ditopic macrocyclic lanthanide chelates with transition-metal ions. Rigid multimetallic high relaxivity contrast agents for magnetic resonance imaging[J]. Inorg Chem, 2006, 45: 5 092-5 102.
[44]  Ruloff R, van Koten G, Merbach A E.  Novel heteroditopic chelate for self-assembled gadolinium(III) complex with high relax-ivity[J]. Chem Commun, 2004, 842-843.
[45]  Aime S, Botta M, Crich S G, et al. A macromolecular Gd (III) complex as pH-responsive relaxometric probe for MRI applications[J]. Chem Commun, 1999, 1 577-1 578.
[46]  Aime S, Fedeli F, Sanino A, et al. A R₂/R₁ ratiometric procedure for a concentration-independent, pHResponsive, Gd(Ⅲ)-Based MRI Agent[J]. J Am Chem Soc, 2006, 128：11 326-11 327.
[47]  Hovland R, GlΦgârd C, Aasen A J, et al. Gadolinium DO3A derivatives mimicking phospholipids; preparation and in vitro evalua-tion as pH responsive MRI contrast agents[J]. J Chem Soc, Perkin Trans  2, 2001, 929-933.
[48]  Zhang S, Wu K, Sherry A D. A Novel pH-Sensitive MRI Contrast Agent\[J\].  Angew Chem Int Ed, 1999, 38：3 192-3 194.
[49]  Raghunand N, Howison C, Sherry A D, et al. Renal and systemic pH imaging by contrast-enhanced MRI\[J\].  Magn Reson Med, 2003, 49：249-257.
[50]  Woods M, Zhang S, Ebron V H, et al. pH-sensitive modulation of the second hydration sphere in lanthanide(III) tetraamide- DOTA complexes: A novel approach to smart MR contrast media[J]. Chem Eur J, 2003, 9：4 634-4 640.
[51]  Woods M, Kiefer G E, Bott S, et al. Synthesis, Relaxometric and photophysical properties of a new pHresponsive MRI contrast agent: The effect of other ligating groups on dissociation of a p-Nitrophenolic pendant arm[J]. J Am Chem Soc, 2004, 126：9 248-9 256.
[52]  Zhang S, Sun D, Li X, et al. Synthesis and solvent enhanced relaxation property of water-soluble endohedral metallofullerenols[J]. Fullerene Sci Technol, 1997, 5：1 635-1 643.
[53]  Mikawa M, Kato H, Okumura M, et al. Paramagnetic water-soluble metallofuller- enes having the highest relaxivity for MRI con-trast agents[J].  Bioconjugate Chem, 2001, 12：510-514.
[54]  Tóth E, Bolskar R D, Borel A, et al. Water-soluble gadofullerenes: toward high-relaxivity, pH-responsive MRI contrast agents[J]. J Am Chem Soc, 2005, 127：799-805.